Biodexa Pharmaceuticals plc American Depositary Shs

Go to Biodexa Pharmaceuticals plc American Depositary Shs Website

$7.03

0.05 (0.72%)
Live
Previous Close

$6.98

Day Range

$6.8005 - $7.1999

Previous Day Range

$6.6228 - $7.3217

Market Cap

$33.8 million USD

Day Vol.

26323

Previous Day Vol.

36737

Currency

USD

Primary Exchange

Nasdaq

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder ca...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Biodexa Pharmaceuticals Plc reported updated data on a Phase 1 study of its drug MX110 in the treatment of recurrent glioblastoma, with two out of four patients in the study now deceased.

Related tickers: BDRX.

Read Full Article

Biodexa Pharmaceuticals Plc reported updated data on a Phase 1 study of its drug MX110 in the treatment of recurrent glioblastoma, with two out of four patients in the study now deceased.

Related tickers: BDRX.

Read Full Article
Trending Tickers

Please sign in to view